Literature DB >> 12528100

Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned?

Vibeke Strand1, John T Sharp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12528100     DOI： 10.1002/art.10683

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  14 in total

1.  Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis.

Authors:  J van Aken; L R Lard; S le Cessie; J M W Hazes; F C Breedveld; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

Review 2.  [Imaging techniques in rheumatology: conventional radiography in rheumatoid arthritis].

Authors:  R Rau; G Lingg; S Wassenberg; C Schorn; A Scherer
Journal:  Z Rheumatol       Date:  2005-10       Impact factor: 1.372

3.  Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study.

Authors:  Katherine P Liao; Michael E Weinblatt; Jing Cui; Christine Iannaccone; Lori B Chibnik; Bing Lu; Jonathan S Coblyn; Nancy A Shadick; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2011-03-29       Impact factor: 7.580

Review 4.  Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.

Authors:  C B Confavreux; R D Chapurlat
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

5.  Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description.

Authors:  M C Wick; S Lindblad; L Klareskog; R F Van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

Review 6.  [Internist's therapy of rheumatoid arthritis].

Authors:  W Seidel; M Pierer; H Häntzschel
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

Review 7.  Biological agents for rheumatoid arthritis: targeting both physical function and structural damage.

Authors:  Alice Klinkhoff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways.

Authors:  Sakae Tanaka
Journal:  World J Orthop       Date:  2013-01-18

9.  Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate.

Authors:  Stanley B Cohen; Edward Keystone; Mark C Genovese; Paul Emery; Charles Peterfy; Paul Peter Tak; Matt Cravets; Tim Shaw; David Hagerty
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

Review 10.  Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years.

Authors:  Mahboob U Rahman; Jacqui Buchanan; Mittie K Doyle; Elizabeth C Hsia; Timothy Gathany; Shreekant Parasuraman; Daniel Aletaha; Eric L Matteson; Philip G Conaghan; Edward Keystone; Désireé van der Heijde; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2011-06-27       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.